BioSpace News Archive

Numerate, the world’s leading computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery has acquired DeepCrystal’s small molecule design platform.

RTI Surgical, Inc., a global surgical implant company, today announced the introduction of TETRAfuse 3D Technology, providing surgeons a solution they have been seeking.

Auspherix Limited, the anti-infectives company meeting the urgent need for new antibiotics by developing a novel class of antibacterials, today announced that it is presenting proprietary bioanalytical methods to characterise the in vivo pharmacokinetic profile and PK/PD relationship of its compounds, following systemic dosing in rodents.

xCell today reports its revenues for the third quarter of 2017 and its cash position as of September 30, 2017.

Relevium Technologies Inc. announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company’s new auditor.

The use of digital pathology has been largely restricted to research applications.

Amgen today announced that it will report its third quarter financial results on Wednesday, Oct. 25, 2017, after the close of the U.S. financial markets.

Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.

Biofilms are surface-attached communities of bacterial or fungal cells that are enmeshed in an extensive extracellular matrix which makes them more resistant to both antibiotics and the immune system.

Medeon Biodesign is pleased to announce that its innovative laparoscopic port site closure device, AbClose, successfully closed more than 50 wounds in a variety of laparoscopic surgeries.